p16(INK4A) mediates cyclin dependent kinase 4 and 6 inhibition in senescent prostatic epithelial cells

Cancer Research

Volumn 60, Issue 10, 2000, Pages 2616-2622

  Sandhu, Charanjit ^a   Peehl, Donna M ^b   Slingerland, Joyce ^a  

^a Sunnybrook and Women's College Health Sciences Centre   (Canada)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; PROTEIN P16; PROTEIN P21; PROTEIN P27; CDK2 PROTEIN, HUMAN; CDK4 PROTEIN, HUMAN; CDK6 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 6; ONCOPROTEIN; PROTEIN P16INK4A; PROTEIN SERINE THREONINE KINASE;

ADULT; ARTICLE; CARCINOGENESIS; CATALYSIS; CELL AGING; CELL CYCLE PHASE; CELL MATURATION; COMPLEX FORMATION; ENZYME INHIBITION; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; CELL CULTURE; CELL CYCLE; CELL SEPARATION; DRUG ANTAGONISM; ENZYMOLOGY; EPITHELIUM CELL; FLOW CYTOMETRY; ISOELECTRIC FOCUSING; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROSTATE;

CDC2-CDC28 KINASES; CELL AGING; CELL CYCLE; CELL SEPARATION; CELLS, CULTURED; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; EPITHELIAL CELLS; FLOW CYTOMETRY; HUMANS; ISOELECTRIC FOCUSING; MALE; PHOSPHORYLATION; PROSTATE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS;

EID: 0034656419     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Hayflick, L. The limited in vitro lifetime of diploid cell strains. Exp. Cell Res., 37: 614-636, 1965.
2. Hayflick, L., and Moorhead, P. S. The serial cultivation of human diploid cell strains. Exp. Cell Res., 25: 585-621, 1961.
3. Martin, G. M., Sprague, C. A., and Epstein, C. J. Replicative life-span of cultivated human cells. Effects of donor's age, tissue, and genotype. Lab. Investig., 23: 86-92, 1970.
4. Rohme, D. Evidence for a relationship between longevity of mammalian species and life spans of normal fibroblasts in vitro and erythrocytes in vivo. Proc. Natl. Acad. Sci. USA, 78: 5009-5013, 1981.
5. Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., and Pereira-Smith, O. A biomarker that identifies senescent human cells in culture and in aging skin in viva. Proc. Natl. Acad. Sci. USA, 92: 9363-9367, 1995.
6. Vojta, P. J., and Barrett, J. C. Genetic analysis of cellular senescence. Biochim. Biophys. Acta, 1242: 29-41, 1995.
7. Sommerfeld, H. J., Meeker, A. K., Piatyszek, M. A., Bova, G. S., Shay, J. W., and Coffey, D. S. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res., 56: 218-222, 1996.
8. Zhang, W., Kapusta, L. R., Slingerland, J. M., and Klotz, L. H. Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium. Cancer Res., 58: 619-621, 1998.
9. Scates, D. K., Muir, G. H., Venitt, S., and Carmichael, P. L. Detection of telomerase activity in human prostate: a diagnostic marker for prostatic cancer? Br. J. Urol., 80: 263-268, 1997.
10. Lin, Y., Uemura, H., Fujinami, K., Hosaka, M., Harada, M., and Kubota, Y. Telomerase activity in primary prostate cancer. J. Urol., 157: 1161-1165, 1997.
11. van Steenbrugge, G. J., Groen, M., van Dongen, J. W., Bolt, J., van der Korput, H., Trapman, J., Hasenson, M., and Horoszewicz, J. The human prostatic carcinoma cell line LNCaP and its derivatives. An overview, Urol. Res., 17: 71-77, 1989.
12. Kaighn, M. E., Narayan, K. S., Ohnuki, Y., Lechner, J. F., and Jones, L. W. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Investig. Urol., 17: 16-23, 1979.
13. Webber, M. M., Bello, D., and Quader, S. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part 3. Oncogenes, suppressor genes, and applications. Prostate, 30: 136-142, 1997.
14. 1 phase progression: cycling on cue. Cell, 79: 551-555, 1994.
15. Morgan, D. O. Principles of Cdk regulation. Nature (Lond.), 374: 131-134, 1995.
16. Solomon, M. J., and Kaldis, P. Regulation of CDKs by phosphorylation. Results Probl. Cell Differ., 22: 79-109, 1998.
17. Dowdy, S. F., Hinds, P. W., Louie, K., Reed, S. I., Arnold, A., and Weinberg, R. A. Physical interaction of the retinoblastoma protein with human D cyclins. Cell, 73: 499-511, 1993.
18. Ewen, M. E., Sluss, H. K., Whitehouse, L. L., and Livingston, D. M. TGF-β inhibition of cdk4 synthesis is linked to cell cycle arrest. Cell, 74: 1009-1020, 1993.
19. 1 cyclin-dependent kinases. Genes Dev., 9: 1149-1163, 1995.
20. 1-phase progression. Genes Dev., 13: 1501-1512, 1999.
21. Hengst, L., Gopfert, U., Lashuel, H. A., and Reed, S. I. Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1). Genes Dev., 12: 3882-3888, 1998.
22. Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., and Barrett, J. C. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA, 93: 13742-13747, 1996.
23. Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S., and Paters, G. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol., 16: 859-867, 1996.
24. Palmero, I., McConnell, B., Parry, D., Brookes, S., Hara, E., Bates, S., Jat, P., and Peters, G. Accumulation of p16INK4a in mouse fibroblasts as a function of replicative senescence and not of retinoblastoma gene status. Oncogene, 15: 495-503, 1997.
25. Zindy, F., Quelle, D. E., Roussel, M. F., and Sherr, C. J. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene, 15; 203-211, 1997.
26. Reznikoff, C. A., Yeager, T. R., Belair, C. D., Savelieva, E., Puthenveettil, J. A., and Stadler, W. M. Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. Cancer Res., 56: 2886-2890, 1996.
27. Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., and Smith, J. R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res., 211: 90-98, 1994.
28. CIP1/WAF1 gene in normal diploid human fibroblasts. Science (Washington DC), 277: 831-834, 1997.
29. Cairns, P., Polascik, T. J., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., Rutter, J. L., Buckler, A., Gabrielson, E., Tockman, M., Cho, K. R., Hedrick, L., Bova, G. S., Isaacs, W., Koch, W., Schwab, D., and Sidransky, D. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat. Genet., 11: 210-212, 1995.
30. Tsihlias, J., Kapusta, L., and Slingerland, J. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. Annu. Rev. Med., 50: 401-423, 1999.
31. Park, D. J., Wilczynski, S. P., Pham, E. Y., Miller, C. W., and Koeffler, H. P. Molecular analysis of the INK4 family of genes in prostate carcinomas. J. Urol., 157: 1995-1999, 1997.
32. Tamimi, Y., Bringuier, P. P., Smit, F., van Bokhoven, A., Debruyne, F. M., and Schalken, J. A. p16 mutations/deletions are not frequent events in prostate cancer. Br. J. Cancer, 74: 120-122, 1996.
33. Jarrard, D. F., Bova, G. S., Ewing, C. M., Pin, S. S., Nguyen, S. H., Baylin, S. B., Cairns, P., Sidransky, D., Herman, J. G., and Isaacs, W. B. Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer. Genes Chromosomes Cancer, 19: 90-96, 1997.
34. Chi, S. G., deVere, W. R., Muenzer, J. T., and Gumerlock, P. H. Frequent alteration of CDKN2 [p16(INK4A)/MTS1] expression in human primary prostate carcinomas. Clin. Cancer Res., 3: 1889-1897, 1997.
35. Peehl, D. M. Culture of human prostatic epithelial cells. In: R. I. Freshney (ed.), Culture of Epithelial Cells, pp. 159-180. New York: Wiley-Liss, 1992.
36. Schmid, H. P., and McNeal, J. E. An abbreviated standard procedure for accurate tumor volume estimation in prostate cancer. Am. J. Surg. Pathol., 16: 184-191, 1992.
37. Lees, E., Faha, B., Dulic, V., Reed, S. I., and Harlow, E. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev., 6: 1874-1885, 1992.
38. 1 and S phases of the mammalian cell cycle. Oncogene, 17: 2637-2643, 1998.
39. Yamashita, M., Fukada, S., Yoshikuni, M., Bulet, P., Hirai, T., Yamaguchi, A., Lou, Y. H., Zhao, Z., and Nagahama, Y. Purification and characterization of maturation-promoting factor in fish. Dev. Biol., 1: 8-15, 1992.
40. Enders, G. H., Koh, J., Rustigi, A. K., Missero, C., and Harlow, E. p16 inhibition of transformed and primary squamous epithelial cells. Oncogene, 12: 1239-1245, 1995.
41. 1-S phase protein kinase. Science (Washington DC), 257: 1958-1961, 1992.
42. LaBaer, J., Garrret, M., Stevenson, L., Slingerland, J., Sandhu, C., Chou, H., Fattaey, A., and Harlow, H. New functional activities for the p21 family of cdk inhibitors. Genes Dev., 11: 847-862, 1997.
43. Slingerland, J. M., Hengst, L., Pan, C-H., Alexander, D., Stampfer, M. R., and Reed, S. I. A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol. Cell. Biol., 14: 3683-3694, 1994.
44. Sherwood, S. W., Rush, D., Ellsworth, J. L., and Schimke, R. T. Defining cellular senescence in IMR-90 cells: a flow cytometric analysis. Proc. Natl. Acad. Sci. USA, 85: 9086-9090, 1988.
45. Cristofalo, V. J., and Sharf, B. B. Cellular senescence and DNA synthesis. Thymidine incorporation as a measure of population age in human diploid cells. Exp. Cell Res., 76: 419-427, 1973.
46. Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., and Harley, C. B. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA, 89: 10114-10118, 1992.
47. Stein, G. H., Drullinger, L. F., Robetorye, R. S., Pereira-Smith, O. M., and Smith, J. R. Senescent cells fail to express cdc2, cycA, and cycB in response to mitogen stimulation. Proc. Natl. Acad. Sci. USA, 88: 11012-11016, 1991.
48. 1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E/Cdk2 and cyclin D1/Cdk2 complexes. Proc. Natl. Acad. Sci. USA, 90: 11034-11038, 1993.
49. Lucibello, F. C., Sewing, A., Brusselbach, S., Burger, C., and Muller, R. Deregulation of cyclins D1 and E and suppression of cdk2 and cdk4 in senescent human fibroblasts. J. Cell Sci., 105: 123-133, 1993.
50. 1/S cell cycle mediators in cellular senescence. Exp. Cell Res., 209: 231-237, 1993.
51. Sdi1/Cip1/Waf1/Imda-6 and expression of other cyclin-dependent kinase inhibitors in senescent human cells. Mol. Cell. Differ., 4: 113-126, 1996.
52. Sayama, K., Shirakata, Y., Midorikawa, K., Hanakawa, Y., and Hashimoto, K. Possible involvement of p21 but not of p16 or p53 in keratinocyte senescence. J. Cell. Physiol. 179: 40-44, 1999.
53. Erickson, S., Sangfelt, O., Heyman, M., Castro, J., Einhorn, S., and Grander, D. Involvement of the Ink4 proteins p16 and p15 in T-lymphocyte senescence. Oncogene, 17: 595-602, 1998.
54. Jarrard, D. F., Sarkar, S., Shi, Y., Yeager, T. R., Magrane, G., Kinoshita, H., Nassif, N., Meisner, L., Newton, M. A., Waldman, F. M., and Reznikoff, C. A. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells. Cancer Res., 59: 2957-2964, 1999.
55. INK4B-cdk4 complexes and inhibits cyclin D1/cdk4 association in human mammary epithelial cells. Mol. Cell. Biol., 17: 2458-2467, 1997.
56. Parry, D., Bates, S., Mann, D. J., and Peters, G. Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO J., 14: 503-511, 1995.
57. Kip1. EMBO J., 16: 5334-5344, 1997.
58. Sheaff, R. J., Groudine, M., Gordon, M., Roberts, J. M., and Clurman, B. E. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev., 11: 1464-1478, 1997.
59. Kawada, M., Yamagoe, S., Murakami, Y., Suzuki, K., Mizuno, S., and Uehara, Y. Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway. Oncogene, 15: 629-637, 1997.